IHS Chemical Week

Markets :: Alternative Fuels :: Biorefineries

Blog: A Bumpy, Slow Transformation to Biomaterials?

8:32 AM MDT | October 18, 2010 | Alex Scott

Although it is widely accepted that one day cheap oil will run out, even in a world of seemingly generous government funding some biomaterial technology providers are struggling to deliver the solutions while maintaining profitability.   Verenium (Cambridge, MA), a biotech firm, could be one such company: Laurence Alexander, an analyst with investment bank Jefferies and Company (New York), in a recent report, downgraded forecast 2010 earnings per share for Verenium from $0.35 to a loss of $2.2. Alexander doesn’t opt for a positive stance in 2011...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa